Buspirone vs. Hydroxyzine: Anxiety Treatment for PI Cases

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 4, 2026 | 8 min read

Buspirone (BuSpar) and hydroxyzine (Vistaril/Atarax) are non-benzodiazepine anxiolytics used in personal injury cases. This comparison explains their mechanisms, prescribing rationale, and what each signals on a pharmacy lien.

Buspirone is a serotonin 5-HT1A partial agonist prescribed for generalized anxiety disorder, while hydroxyzine is an antihistamine with anxiolytic properties used for acute and situational anxiety. Both appear in personal injury pharmacy lien records as alternatives to benzodiazepines, and the prescriber's selection reflects a clinical decision to manage post-traumatic anxiety without the dependency risks and DEA scheduling concerns associated with controlled anxiolytics.

• Buspirone (BuSpar) is FDA-approved for generalized anxiety disorder and works through serotonin receptor modulation rather than GABAergic sedation
• Hydroxyzine (Vistaril/Atarax) is FDA-approved for anxiety and is a first-generation antihistamine with sedative-anxiolytic properties
• Neither medication is a controlled substance, making both preferable to benzodiazepines from a prescribing and documentation standpoint
• Buspirone requires 2-4 weeks to reach full efficacy, while hydroxyzine provides immediate anxiolysis within 30-60 minutes
• LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report contextualizing anxiety medication choices within the overall injury treatment timeline

Mechanism of Action

Buspirone acts as a partial agonist at serotonin 5-HT1A receptors, modulating serotonergic neurotransmission in anxiety-related brain circuits. Unlike benzodiazepines, buspirone does not interact with GABA receptors and therefore does not produce the sedation, muscle relaxation, or cognitive impairment associated with GABAergic agents. Its anxiolytic effect develops gradually over 2-4 weeks of consistent dosing, similar to antidepressant onset patterns.

Hydroxyzine blocks histamine H1 receptors in the central nervous system, producing sedation and anxiolysis. It also has anticholinergic and antiserotonergic properties that contribute to its calming effect. Unlike buspirone, hydroxyzine provides rapid onset anxiolysis, making it effective for acute anxiety episodes and situational distress. It is available in two salt forms: hydroxyzine pamoate (Vistaril, preferred for anxiety) and hydroxyzine hydrochloride (Atarax, often used for itching).

Side-by-Side Comparison

Clinical Significance for Personal Injury

Post-traumatic anxiety is a pervasive consequence of personal injury events. Patients involved in motor vehicle collisions, workplace accidents, assaults, and other traumatic incidents frequently develop anxiety that manifests as hypervigilance, avoidance behaviors, panic attacks, and generalized worry. The prescribing of dedicated anxiolytics in the pharmacy record documents this psychological dimension of the injury.

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "The choice between buspirone and hydroxyzine tells us about the nature and timeline of the patient's anxiety. Buspirone indicates the prescriber is managing chronic, persistent anxiety that requires daily medication. Hydroxyzine suggests acute anxiety episodes or situational distress that needs immediate relief. Both document real psychological injury from the traumatic event."

The non-controlled status of both medications is significant from a prescribing perspective. Many physicians managing PI patients prefer to avoid benzodiazepines due to concerns about dependency, cognitive impairment, and the medicolegal complications of prescribing Schedule IV controlled substances during active litigation. Buspirone and hydroxyzine provide documented anxiety treatment without these risks.

Prescribing Patterns in PI Cases

Buspirone is typically chosen when:

• The patient has chronic generalized anxiety that developed or worsened after the injury
• Long-term anxiolytic therapy is anticipated (months to years)
• The patient is on concurrent opioids and the prescriber wants to avoid benzodiazepine-opioid respiratory depression risk
• The patient has a history of substance use that contraindicates controlled substances

Hydroxyzine is typically chosen when:

• The patient has acute anxiety episodes or situational triggers (driving anxiety after an MVA, for example)
• Rapid onset is needed for panic-like symptoms or breakthrough anxiety
• The patient also needs help with injury-related sleep disruption (hydroxyzine's sedation is helpful at bedtime)
• The prescriber is using it as a bridge while waiting for buspirone or an SSRI to reach therapeutic effect

Many PI patients are prescribed both concurrently: buspirone for baseline daily anxiety management and hydroxyzine as needed for acute episodes. This combination on a pharmacy lien demonstrates a comprehensive approach to anxiety management with multiple symptom modalities.

Documentation and Case Value

Anxiety pharmacotherapy on a pharmacy lien adds a documented psychiatric injury component to the case. From a case valuation standpoint:

• Buspirone on a sustained basis documents chronic anxiety requiring ongoing medication management, supporting claims for long-term psychological impact
• Hydroxyzine prescribed PRN with frequent refills documents recurring acute anxiety episodes that disrupt daily functioning
• Both medications together demonstrate multi-layered anxiety management consistent with significant post-traumatic psychological distress

The pharmacy dispensing record provides objective timestamps for each prescription fill, creating an anxiety treatment timeline that parallels the physical injury recovery. Gaps in anxiety medication fills may indicate periods of symptom remission or, conversely, treatment non-adherence that defense counsel could highlight.

Related Resources

• Hydroxyzine for Anxiety and Sleep After Injury
• Buspirone for Anxiety After Injury
• PTSD Medication Management in Personal Injury
• Hydroxyzine vs. Benzodiazepines for PI Anxiety